Calysta receives $30 million investment from BP Ventures
Alternative protein producer Calysta has announced a $30 million investment from BP Ventures to support a worldwide rollout of Calysta’s FeedKind protein, which the company claims can help improve global food security.
Alternative protein producer Calysta has announced a $30 million investment from BP Ventures to support a worldwide rollout of Calysta’s FeedKind protein, which the company claims can help improve global food security.
The investment will help Calysta expand production of its sustainable single-cell protein, which is produced through a proprietary, commercially validated gas fermentation process using naturally occurring, non-GM microbes with the ability to use methane as their energy source. Through extensive customer trials around the world, FeedKind protein has been demonstrated to be an effective, safe, and nutritious feed ingredient, says the company.
“Welcoming BP as a partner is a tremendous step forward for FeedKind protein and the best indicator yet that Calysta’s solution to food insecurity in a resource-constrained world can and will achieve global scale,” said Alan Shaw, Calysta president and CEO. “The problems facing our food production supply chains have never been clearer, with increasing evidence that land and water scarcity are key challenges to meeting future demand for protein. FeedKind makes more from less, producing feed for livestock, fish, and pets while making smarter use of our resources.”
FeedKind is already being produced from the company’s Market Introduction Facility (MIF) in Teesside, England, to support market development activities with leading animal nutrition companies around the world.